pre-miRNA Information
pre-miRNA hsa-mir-210   
Genomic Coordinates chr11: 568089 - 568198
Synonyms MIRN210, mir-210, MIR210
Description Homo sapiens miR-210 stem-loop
Comment This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-210-3p
Sequence 66| CUGUGCGUGUGACAGCGGCUGA |87
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 12 11 - 568122 25582055 MiREDiBase
A-to-I 14 11 - 568120 26028588 MiREDiBase
C-to-U 1 11 - 568133 26209130 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs753825152 1 dbSNP
rs759616365 3 dbSNP
rs1247955373 6 dbSNP
rs558661304 9 dbSNP
rs1490451308 13 dbSNP
rs1344162213 14 dbSNP
rs745930382 15 dbSNP
rs1220183952 16 dbSNP
rs1355496181 17 dbSNP
rs1280245998 19 dbSNP
rs781628850 20 dbSNP
rs1241231800 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Urine Quantitative real-time reverse transcription PCR
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Low Blood Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol ZNF607   
Synonyms -
Description zinc finger protein 607
Transcript NM_001172677   
Other Transcripts NM_032689   
Expression
Putative miRNA Targets on ZNF607
3'UTR of ZNF607
(miRNA target sites are highlighted)
>ZNF607|NM_001172677|3'UTR
   1 TAGAGAAATTGTGGCATATACAGGTAGTAAAGAAAGCACATTGTGTCAATGGATTTATCCCACTGAACAATTTGAATGAA
  81 GACAATGTGGAATGGCTTTGAGATACAGTTCAGTTTTTATTAGGCATCAATTTGTATTGGTGTGAACTTTTCAAAATGTA
 161 AATCATATATGCAGTTTCTTTGGTATGACCTGTGTTAACTCAGATTCAGAGAATTTATAATGTATTTTTTTAATAACATA
 241 AGAAAACTTTTCTGATATTCCTCTAGTTTTGGATTGCCAAAATATTCACAGTAGAGGAAAACTGAGAAAACGTAGGAAAC
 321 CATTCTTTATACTTGCATGTAAACATCTTCCAGCAACAATCATTTATTGTTAAACCTGGAAAAAGCCATTACACAGGAAA
 401 CCTCTGTTGATATAAGCGATGATGGGAAAGGCTATTTAGCCACTCTGCATATTTAATGCTCATGATCAACATCTGCTTCC
 481 TATAGCTGGGATGATATGGGGGAAGATATTTATCCCTTCTGGGGATCATATATAAATGATGATAGTAGTACCTACAGTAT
 561 AGTGCTGTTAGAATTACATGAGTTAGATGTGGAGGTCAGAGTGGAAGCAGGTGTGAGAGGGTCCCGCAGAAGAAAACATG
 641 GCTGCCAAAGTGTTTGAGTCCATCGGCAAGTTTGGCCTGGCCTTAGCTGTTGCAGGAGGCATGGTGAACTCTGCCTTATG
 721 TAATGTGGATGCTGGGCACAGAGCTGCCATCTTTGACCAATTCCGTGGAGTACAGAACATTGTGGTAGGGGAAGGGACTC
 801 ACTTTCTCATCCCATGTGTACAAAAACCAATTATCTTTGACTGCTGTTCTCAACCACGTAGTGCGCCAGTCATCACTGGT
 881 AGCAAAGATTTACAGAATGTCAACATCACACTGTGCATCCTCTTCCGGCCCATCACTAGCCAGCTTCCTCGCATCTTCAC
 961 CAGCATTGGAGAGGACTACGATGAGTGTGTGCTGCCGTTCATTACCACGGAGATCCTCAAGTCACTGGTGGCTCGCTTTG
1041 ATGCTGGAGAACTAATCACCCAGAGGGAGCTGGTCTCCAGCCAGGTGAGCAACAACCTTATGGAGTGAGCAGCCACCTTT
1121 GGGCTCATTCTGGACGACGTGTCTTTGACACATCTGACCTTCTTGAAGGAGTTAACAGACAGGTGGCCCCCCAGGAAGCA
1201 GAGAGCGCCAGATTTGTGGTGGAAAAGGCGGCCATCATCTCTGCTGAGGGTGACTCCAAGGCAGCTGAGCTGATCGCCAA
1281 CTCACTGGCCACTGCAGGGGACGGCCAGAGCGAGCTGTGCAAGCTGGAAGCTGCAGAAGACATTGCATACCAGCTCTCAT
1361 GCTCTCGGAACATCACCTGCCTGCCGGCAGGGCAGTCCGTGCTCCTCCAGCTGCCCTAGTGAGGCCCCAGCCTACCTGCA
1441 CCTCCGTGAGGCAACTGGGCCACAGCCCCGATGATTCGTAACACCACCTTTCGCCCTCACCCCAGAAATCACTGAAATTT
1521 CATGATTGGCTTAAAGTGAAGGAAGTAAAGGTAAAATCACTTCAGATCTCTAAAAAACAAAGAATTACATGAGTTAGTAC
1601 ATGAAAAAATTATGGGAAACTACATGAAATATACTGTTACGTTCAATAAACATTAGCTTCTGTATATAATAATATCA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' aguCGGCGACAGU--GUGCGUguc 5'
             ||:|:| |||  ||||:|   
Target 5' actGCTGTTCTCAACCACGTAgtg 3'
840 - 863 113.00 -15.70
2
miRNA  3' agUCGG--CGAC-AGUG--UGCGUGuc 5'
            |||:  |||| ||:|  || |||  
Target 5' gcAGCTGAGCTGATCGCCAACTCACtg 3'
1261 - 1287 112.00 -18.50
3
miRNA  3' agucggCGACAGU--GUGCGUGUc 5'
                |: || |   | ||||| 
Target 5' atacagGTAGTAAAGAAAGCACAt 3'
18 - 41 110.00 -8.40
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30112057 5 COSMIC
COSN22849071 29 COSMIC
COSN30523260 58 COSMIC
COSN31512332 90 COSMIC
COSN30526626 92 COSMIC
COSN512303 145 COSMIC
COSN30170075 177 COSMIC
COSN31558239 211 COSMIC
COSN31567514 538 COSMIC
COSN31524268 549 COSMIC
COSN31550445 562 COSMIC
COSN26505461 625 COSMIC
COSN6668527 640 COSMIC
COSN30470636 641 COSMIC
COSN26572410 643 COSMIC
COSN31502881 661 COSMIC
COSN26669552 664 COSMIC
COSN27006337 702 COSMIC
COSN28805008 708 COSMIC
COSN17183050 719 COSMIC
COSN26578275 747 COSMIC
COSN31574989 765 COSMIC
COSN26603595 789 COSMIC
COSN30470400 795 COSMIC
COSN30117671 877 COSMIC
COSN30101361 887 COSMIC
COSN30476274 890 COSMIC
COSN30535910 893 COSMIC
COSN8605698 899 COSMIC
COSN24306693 911 COSMIC
COSN30100457 912 COSMIC
COSN2529482 930 COSMIC
COSN18742945 931 COSMIC
COSN31512985 943 COSMIC
COSN8260168 951 COSMIC
COSN30138565 963 COSMIC
COSN31543574 968 COSMIC
COSN31533418 979 COSMIC
COSN30114181 1035 COSMIC
COSN30150324 1047 COSMIC
COSN26859349 1079 COSMIC
COSN31607154 1135 COSMIC
COSN31570073 1138 COSMIC
COSN30531840 1200 COSMIC
COSN31546296 1249 COSMIC
COSN13801933 1275 COSMIC
COSN26269239 1289 COSMIC
COSN30530306 1302 COSMIC
COSN31554678 1304 COSMIC
COSN1215139 1321 COSMIC
COSN30116152 1335 COSMIC
COSN32058101 1358 COSMIC
COSN30137960 1384 COSMIC
COSN24403025 1389 COSMIC
COSN26722210 1510 COSMIC
COSN27161274 1592 COSMIC
COSN20740439 1620 COSMIC
COSN23091907 1635 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs751800717 1 dbSNP
rs764464563 2 dbSNP
rs1293182880 3 dbSNP
rs758495663 11 dbSNP
rs533119644 13 dbSNP
rs765711545 16 dbSNP
rs192270194 22 dbSNP
rs776928995 24 dbSNP
rs886498862 39 dbSNP
rs368009766 43 dbSNP
rs1466576617 47 dbSNP
rs374093712 49 dbSNP
rs1300777026 64 dbSNP
rs1307010414 80 dbSNP
rs1378937329 81 dbSNP
rs1240785885 91 dbSNP
rs777261227 92 dbSNP
rs1353970540 94 dbSNP
rs1010536297 119 dbSNP
rs893473139 128 dbSNP
rs539350399 130 dbSNP
rs1001937731 131 dbSNP
rs1040018889 134 dbSNP
rs762671933 142 dbSNP
rs1236426425 143 dbSNP
rs906052622 150 dbSNP
rs1369253397 155 dbSNP
rs1171110488 168 dbSNP
rs925792752 170 dbSNP
rs1179787406 175 dbSNP
rs1368292708 183 dbSNP
rs1471991231 184 dbSNP
rs1164660128 190 dbSNP
rs761246910 190 dbSNP
rs1464654412 192 dbSNP
rs189582689 196 dbSNP
rs1430788963 201 dbSNP
rs565308927 202 dbSNP
rs1401830774 212 dbSNP
rs1046293310 222 dbSNP
rs1447492123 232 dbSNP
rs1333398550 236 dbSNP
rs547092199 245 dbSNP
rs1171003210 246 dbSNP
rs978542878 250 dbSNP
rs945814943 254 dbSNP
rs1218231984 258 dbSNP
rs1014520410 260 dbSNP
rs529507024 261 dbSNP
rs1256290361 263 dbSNP
rs886652783 280 dbSNP
rs1047965997 281 dbSNP
rs912961324 282 dbSNP
rs930680970 287 dbSNP
rs2287229 289 dbSNP
rs1189971020 293 dbSNP
rs1238408499 296 dbSNP
rs540787733 312 dbSNP
rs1481993344 313 dbSNP
rs1425204935 316 dbSNP
rs1253871592 321 dbSNP
rs980355957 328 dbSNP
rs943425606 336 dbSNP
rs1399890376 337 dbSNP
rs1016457634 342 dbSNP
rs747757009 352 dbSNP
rs1005025346 357 dbSNP
rs886553769 367 dbSNP
rs1346842584 375 dbSNP
rs1277962571 376 dbSNP
rs1030814138 380 dbSNP
rs911743291 383 dbSNP
rs1228172170 392 dbSNP
rs1255926789 400 dbSNP
rs1220551614 401 dbSNP
rs1202693463 402 dbSNP
rs1281557239 403 dbSNP
rs1345301640 406 dbSNP
rs1191108851 408 dbSNP
rs1278377210 409 dbSNP
rs375716022 413 dbSNP
rs966653684 417 dbSNP
rs150986505 418 dbSNP
rs1173057134 421 dbSNP
rs1359698652 422 dbSNP
rs989388618 426 dbSNP
rs1038971045 434 dbSNP
rs957719908 445 dbSNP
rs942638225 446 dbSNP
rs545850096 449 dbSNP
rs1382987705 461 dbSNP
rs1300749048 465 dbSNP
rs904418623 469 dbSNP
rs2909091 470 dbSNP
rs769211534 473 dbSNP
rs1304742253 482 dbSNP
rs945850073 497 dbSNP
rs1332635026 502 dbSNP
rs1288590100 506 dbSNP
rs1486030527 507 dbSNP
rs200511504 514 dbSNP
rs1264716775 517 dbSNP
rs1434349703 518 dbSNP
rs913018386 522 dbSNP
rs1379539634 524 dbSNP
rs1437608336 525 dbSNP
rs1387971458 536 dbSNP
rs1160296179 545 dbSNP
rs970853501 551 dbSNP
rs1024482998 556 dbSNP
rs1014877526 560 dbSNP
rs1388691971 571 dbSNP
rs1426141014 578 dbSNP
rs1158272644 583 dbSNP
rs112990056 589 dbSNP
rs73621573 594 dbSNP
rs568089249 604 dbSNP
rs185469562 608 dbSNP
rs142866942 610 dbSNP
rs1235468101 622 dbSNP
rs1243641858 625 dbSNP
rs34625192 626 dbSNP
rs779543999 626 dbSNP
rs1263276428 629 dbSNP
rs566642261 632 dbSNP
rs983643593 637 dbSNP
rs950947003 640 dbSNP
rs911926280 662 dbSNP
rs1030464686 664 dbSNP
rs1226239328 665 dbSNP
rs1422974722 676 dbSNP
rs1164382809 678 dbSNP
rs998010555 680 dbSNP
rs557812533 681 dbSNP
rs539474445 693 dbSNP
rs192590242 694 dbSNP
rs1399604443 701 dbSNP
rs913722966 704 dbSNP
rs55743020 708 dbSNP
rs1333900137 720 dbSNP
rs957914610 722 dbSNP
rs745841797 723 dbSNP
rs1310154876 724 dbSNP
rs980398448 724 dbSNP
rs1042948990 726 dbSNP
rs1010102654 727 dbSNP
rs891634167 728 dbSNP
rs1315504623 734 dbSNP
rs970418395 736 dbSNP
rs563880065 749 dbSNP
rs756232097 760 dbSNP
rs746868489 764 dbSNP
rs1179839394 765 dbSNP
rs1258012225 767 dbSNP
rs950975321 768 dbSNP
rs1390866246 772 dbSNP
rs927001867 773 dbSNP
rs1044114291 785 dbSNP
rs941659453 789 dbSNP
rs909503983 792 dbSNP
rs1464096801 794 dbSNP
rs983712004 796 dbSNP
rs1355567001 797 dbSNP
rs1026418081 801 dbSNP
rs529598985 802 dbSNP
rs187253160 806 dbSNP
rs899391339 807 dbSNP
rs1183590752 814 dbSNP
rs547236523 816 dbSNP
rs1415068434 817 dbSNP
rs2909090 818 dbSNP
rs1337811139 827 dbSNP
rs1219861041 857 dbSNP
rs923451072 858 dbSNP
rs59096662 860 dbSNP
rs1207901158 862 dbSNP
rs1206389903 864 dbSNP
rs139651004 865 dbSNP
rs1017623492 869 dbSNP
rs1188961686 874 dbSNP
rs1000859701 888 dbSNP
rs968011440 889 dbSNP
rs1052310317 910 dbSNP
rs530464967 912 dbSNP
rs1174548716 921 dbSNP
rs891688958 922 dbSNP
rs757118868 926 dbSNP
rs182911172 927 dbSNP
rs533685511 928 dbSNP
rs1401443757 931 dbSNP
rs936578550 932 dbSNP
rs1230570563 934 dbSNP
rs1366266948 938 dbSNP
rs1217430301 943 dbSNP
rs1380301391 946 dbSNP
rs957507863 948 dbSNP
rs1270004605 949 dbSNP
rs926486079 950 dbSNP
rs541415717 951 dbSNP
rs1367628752 954 dbSNP
rs887443937 964 dbSNP
rs1047367358 976 dbSNP
rs1487469627 979 dbSNP
rs949103331 980 dbSNP
rs765616972 981 dbSNP
rs976678257 984 dbSNP
rs917574789 990 dbSNP
rs1166787694 993 dbSNP
rs559226926 995 dbSNP
rs1405911246 996 dbSNP
rs982960205 997 dbSNP
rs1378825824 998 dbSNP
rs1402139406 1000 dbSNP
rs951106960 1001 dbSNP
rs1348829433 1008 dbSNP
rs1026449341 1009 dbSNP
rs146296003 1012 dbSNP
rs559189516 1017 dbSNP
rs755100379 1020 dbSNP
rs753898372 1021 dbSNP
rs968068281 1023 dbSNP
rs540858812 1035 dbSNP
rs766491724 1039 dbSNP
rs1017844829 1040 dbSNP
rs1225703933 1045 dbSNP
rs1007796754 1046 dbSNP
rs1192683840 1047 dbSNP
rs1451112211 1058 dbSNP
rs192290556 1060 dbSNP
rs1219385912 1062 dbSNP
rs1254946616 1063 dbSNP
rs988131459 1066 dbSNP
rs1487201742 1067 dbSNP
rs890475357 1070 dbSNP
rs1030308988 1073 dbSNP
rs143629370 1079 dbSNP
rs1010077391 1084 dbSNP
rs1224366689 1085 dbSNP
rs1412550464 1101 dbSNP
rs892517834 1103 dbSNP
rs187946023 1127 dbSNP
rs539910432 1135 dbSNP
rs140031287 1136 dbSNP
rs557326990 1138 dbSNP
rs1329162435 1139 dbSNP
rs112718703 1143 dbSNP
rs1442580759 1158 dbSNP
rs1280370817 1163 dbSNP
rs541095495 1165 dbSNP
rs1226814091 1174 dbSNP
rs1047877864 1178 dbSNP
rs1335499938 1180 dbSNP
rs1198607400 1183 dbSNP
rs1386459228 1183 dbSNP
rs1256648532 1184 dbSNP
rs928966441 1189 dbSNP
rs1045413336 1191 dbSNP
rs1183062379 1193 dbSNP
rs949310979 1206 dbSNP
rs568785022 1207 dbSNP
rs1295381829 1208 dbSNP
rs547293624 1219 dbSNP
rs982436618 1225 dbSNP
rs535281856 1229 dbSNP
rs571049016 1230 dbSNP
rs1353862091 1234 dbSNP
rs1166713597 1237 dbSNP
rs973784677 1245 dbSNP
rs552764640 1274 dbSNP
rs1398469698 1275 dbSNP
rs1410450964 1276 dbSNP
rs1390603114 1278 dbSNP
rs1172585048 1279 dbSNP
rs1431119821 1281 dbSNP
rs1268771367 1285 dbSNP
rs1295312812 1286 dbSNP
rs756286375 1288 dbSNP
rs530634726 1293 dbSNP
rs183407383 1299 dbSNP
rs190696083 1302 dbSNP
rs529644441 1303 dbSNP
rs373991229 1311 dbSNP
rs559247214 1312 dbSNP
rs1203700093 1316 dbSNP
rs1441000846 1316 dbSNP
rs1484221410 1317 dbSNP
rs986803923 1317 dbSNP
rs540921872 1322 dbSNP
rs576665118 1323 dbSNP
rs954954908 1324 dbSNP
rs1257696789 1326 dbSNP
rs767741481 1333 dbSNP
rs988572521 1339 dbSNP
rs1232743307 1341 dbSNP
rs762213763 1347 dbSNP
rs1310676001 1349 dbSNP
rs1171883500 1356 dbSNP
rs7245981 1358 dbSNP
rs1219880912 1360 dbSNP
rs543204662 1361 dbSNP
rs1306082105 1363 dbSNP
rs981364497 1366 dbSNP
rs575713604 1367 dbSNP
rs969939407 1377 dbSNP
rs1328253941 1383 dbSNP
rs1032457595 1385 dbSNP
rs1228820313 1386 dbSNP
rs1274737052 1386 dbSNP
rs76141649 1389 dbSNP
rs1236875335 1390 dbSNP
rs1281474289 1392 dbSNP
rs543519615 1398 dbSNP
rs144374307 1399 dbSNP
rs1379004346 1401 dbSNP
rs1026060621 1405 dbSNP
rs1447041772 1406 dbSNP
rs1198088536 1409 dbSNP
rs993601889 1413 dbSNP
rs901515387 1423 dbSNP
rs1013930456 1437 dbSNP
rs1007785976 1439 dbSNP
rs149640717 1445 dbSNP
rs1180596510 1446 dbSNP
rs1047422299 1449 dbSNP
rs1323493562 1457 dbSNP
rs1382781055 1457 dbSNP
rs1369498817 1458 dbSNP
rs186184816 1464 dbSNP
rs889339961 1466 dbSNP
rs1473868486 1469 dbSNP
rs929679622 1470 dbSNP
rs946869649 1477 dbSNP
rs1043713439 1479 dbSNP
rs1208788780 1484 dbSNP
rs571112920 1492 dbSNP
rs1469798788 1496 dbSNP
rs552761502 1500 dbSNP
rs1194162617 1518 dbSNP
rs537217131 1522 dbSNP
rs1328527180 1530 dbSNP
rs939399249 1532 dbSNP
rs1365697041 1542 dbSNP
rs748955219 1545 dbSNP
rs928005100 1547 dbSNP
rs750447050 1550 dbSNP
rs1392332252 1558 dbSNP
rs1443814609 1561 dbSNP
rs980738882 1563 dbSNP
rs1376637790 1564 dbSNP
rs1389974356 1565 dbSNP
rs969990362 1577 dbSNP
rs4006732 1582 dbSNP
rs1243574637 1585 dbSNP
rs1270779955 1585 dbSNP
rs774815848 1588 dbSNP
rs951904809 1589 dbSNP
rs183270806 1591 dbSNP
rs1479542525 1608 dbSNP
rs1178787809 1609 dbSNP
rs1250964583 1610 dbSNP
rs1351040800 1612 dbSNP
rs1312007490 1616 dbSNP
rs993261493 1622 dbSNP
rs910720957 1632 dbSNP
rs1404151133 1634 dbSNP
rs1166307063 1636 dbSNP
rs547952451 1640 dbSNP
rs769380505 1641 dbSNP
rs1007169081 1643 dbSNP
rs1397632175 1644 dbSNP
rs1385740375 1652 dbSNP
rs1160757211 1656 dbSNP
rs1473817886 1657 dbSNP
rs889391757 1662 dbSNP
rs1233300840 1663 dbSNP
rs1277003787 1672 dbSNP
rs1413336102 1675 dbSNP
rs1206496707 1676 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions LCL35
Disease MIMAT0000267
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in GSM1020022. RNA binding protein: AGO2. Condition:EBV B95-8-infected ...

- Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' agucggcgacAGUGUGCGUGUc 5'
                    ||| ||||||| 
Target 5' ----------UCAAACGCACAa 3'
1 - 12
Article - Skalsky RL; Corcoran DL; Gottwein E; Frank et al.
- PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
CLIP-seq Support 1 for dataset GSM1020022
Method / RBP PAR-CLIP / AGO2
Cell line / Condition LCL35 / EBV B95-8-infected, 4-thiouridine, RNase T1
Location of target site ENST00000355202.4 | 3UTR | UCAAACGCACAAGUGUUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 22291592 / GSE41437
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
COAD 0.68 0.03 0.714 0.02 8 Click to see details
PRAD 0.248 0.04 0.305 0.02 50 Click to see details
STAD -0.283 0.06 -0.242 0.09 32 Click to see details
THCA -0.159 0.11 -0.068 0.3 59 Click to see details
LUAD 0.37 0.12 0.378 0.11 12 Click to see details
HNSC -0.176 0.13 -0.115 0.23 42 Click to see details
CHOL -0.416 0.13 -0.733 0.01 9 Click to see details
KIRC -0.099 0.21 -0.134 0.14 68 Click to see details
LUSC 0.131 0.22 0.266 0.05 38 Click to see details
PCPG 0.739 0.24 1.000 0.5 3 Click to see details
UCEC 0.162 0.25 0.112 0.32 19 Click to see details
ESCA 0.18 0.3 0.182 0.3 11 Click to see details
CESC -0.54 0.32 -0.500 0.33 3 Click to see details
BLCA 0.076 0.38 0.094 0.36 18 Click to see details
KIRP -0.041 0.41 0.084 0.32 32 Click to see details
BRCA 0.016 0.44 0.015 0.45 84 Click to see details
KICH -0.021 0.46 0.002 0.5 25 Click to see details
LIHC -0.003 0.49 0.074 0.31 49 Click to see details
PAAD -0.008 0.5 0.200 0.4 4 Click to see details
PAAD -0.008 0.5 0.200 0.4 4 Click to see details
PAAD -0.008 0.5 0.200 0.4 4 Click to see details
126 hsa-miR-210-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000149 HOXA9 homeobox A9 4 1
MIRT000150 TP53I11 tumor protein p53 inducible protein 11 2 1
MIRT000151 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 1
MIRT000152 HOXA1 homeobox A1 2 1
MIRT000153 FGFRL1 fibroblast growth factor receptor like 1 6 3
MIRT000156 RAD52 RAD52 homolog, DNA repair protein 5 3
MIRT001930 NPTX1 neuronal pentraxin 1 3 2
MIRT002024 EFNA3 ephrin A3 8 8
MIRT003153 BDNF brain derived neurotrophic factor 5 1
MIRT003154 PTPN1 protein tyrosine phosphatase, non-receptor type 1 5 1
MIRT003155 P4HB prolyl 4-hydroxylase subunit beta 6 2
MIRT003156 UBQLN1 ubiquilin 1 3 1
MIRT003157 SERTAD2 SERTA domain containing 2 3 1
MIRT003158 SEH1L SEH1 like nucleoporin 3 1
MIRT003159 NCAM1 neural cell adhesion molecule 1 4 1
MIRT003160 MID1IP1 MID1 interacting protein 1 3 1
MIRT003161 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 3 1
MIRT003162 KIAA1161 myogenesis regulating glycosidase (putative) 3 1
MIRT003163 ISCU iron-sulfur cluster assembly enzyme 6 7
MIRT003164 HOXA3 homeobox A3 3 1
MIRT003165 GPD1L glycerol-3-phosphate dehydrogenase 1 like 7 2
MIRT003166 DENND6A DENN domain containing 6A 3 1
MIRT003167 CPEB2 cytoplasmic polyadenylation element binding protein 2 5 1
MIRT003168 CDK10 cyclin dependent kinase 10 3 1
MIRT003169 ABCB9 ATP binding cassette subfamily B member 9 3 1
MIRT003170 CBX1 chromobox 1 3 1
MIRT003171 XIST X inactive specific transcript (non-protein coding) 4 1
MIRT003172 TNPO1 transportin 1 3 1
MIRT003173 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 3 1
MIRT003174 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 3 1
MIRT003175 NIPBL NIPBL, cohesin loading factor 3 1
MIRT003176 MIB1 mindbomb E3 ubiquitin protein ligase 1 3 1
MIRT003177 HECTD1 HECT domain E3 ubiquitin protein ligase 1 3 1
MIRT003178 ELK3 ELK3, ETS transcription factor 3 1
MIRT003179 DDAH1 dimethylarginine dimethylaminohydrolase 1 4 1
MIRT003180 CLASP2 cytoplasmic linker associated protein 2 3 1
MIRT003181 CHD9 chromodomain helicase DNA binding protein 9 3 1
MIRT003182 ATP11C ATPase phospholipid transporting 11C 3 1
MIRT003183 APC APC, WNT signaling pathway regulator 3 1
MIRT003184 E2F3 E2F transcription factor 3 7 5
MIRT003185 ACVR1B activin A receptor type 1B 2 1
MIRT003916 MRE11A MRE11 homolog, double strand break repair nuclease 2 1
MIRT003917 XPA XPA, DNA damage recognition and repair factor 2 1
MIRT004672 MNT MAX network transcriptional repressor 4 2
MIRT006326 AIFM3 apoptosis inducing factor, mitochondria associated 3 3 2
MIRT006519 CASP8AP2 caspase 8 associated protein 2 4 1
MIRT006663 VMP1 vacuole membrane protein 1 3 2
MIRT006830 TFRC transferrin receptor 3 2
MIRT047002 PFDN2 prefoldin subunit 2 1 1
MIRT047003 U2AF2 U2 small nuclear RNA auxiliary factor 2 1 1
MIRT047004 UBA1 ubiquitin like modifier activating enzyme 1 1 1
MIRT047005 ESPL1 extra spindle pole bodies like 1, separase 1 1
MIRT047006 ACTR1A ARP1 actin related protein 1 homolog A 1 1
MIRT047007 SCN1B sodium voltage-gated channel beta subunit 1 1 1
MIRT047008 RCC2 regulator of chromosome condensation 2 1 1
MIRT053179 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 2 1
MIRT054098 NDUFA4 NDUFA4, mitochondrial complex associated 4 2
MIRT054099 SDHD succinate dehydrogenase complex subunit D 6 4
MIRT054141 STMN1 stathmin 1 3 1
MIRT054142 DIMT1L DIM1 dimethyladenosine transferase 1 homolog 4 2
MIRT054186 ROD1 polypyrimidine tract binding protein 3 3 1
MIRT054203 ALDH5A1 aldehyde dehydrogenase 5 family member A1 4 1
MIRT054204 FOXN3 forkhead box N3 5 2
MIRT054205 MCM3 minichromosome maintenance complex component 3 4 1
MIRT054206 IGFBP3 insulin like growth factor binding protein 3 6 2
MIRT054207 COL4A2 collagen type IV alpha 2 chain 6 2
MIRT054208 INPP5A inositol polyphosphate-5-phosphatase A 4 1
MIRT054209 EHD2 EH domain containing 2 4 1
MIRT054210 SH3BGRL SH3 domain binding glutamate rich protein like 5 2
MIRT054248 PTPN2 protein tyrosine phosphatase, non-receptor type 2 3 1
MIRT054321 LDHA lactate dehydrogenase A 2 1
MIRT054324 LDHB lactate dehydrogenase B 2 1
MIRT054349 HIF1A hypoxia inducible factor 1 alpha subunit 5 2
MIRT054714 FOXP3 forkhead box P3 3 1
MIRT054794 HIF3A hypoxia inducible factor 3 alpha subunit 3 1
MIRT115688 MGRN1 mahogunin ring finger 1 2 3
MIRT170674 INSIG1 insulin induced gene 1 1 1
MIRT437785 BNIP3 BCL2 interacting protein 3 5 2
MIRT438739 KCMF1 potassium channel modulatory factor 1 1 1
MIRT439407 TNPO3 transportin 3 1 1
MIRT439629 SIPA1L3 signal induced proliferation associated 1 like 3 1 1
MIRT439632 SIN3A SIN3 transcription regulator family member A 1 1
MIRT439740 RPL22 ribosomal protein L22 1 1
MIRT439886 PSAP prosaposin 1 1
MIRT439918 PPP1R2 protein phosphatase 1 regulatory inhibitor subunit 2 1 1
MIRT439928 POU2AF1 POU class 2 associating factor 1 1 1
MIRT440033 ICMT isoprenylcysteine carboxyl methyltransferase 2 3
MIRT440255 MEF2D myocyte enhancer factor 2D 1 1
MIRT440491 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 3
MIRT440570 GIT2 GIT ArfGAP 2 1 1
MIRT440647 FCHSD2 FCH and double SH3 domains 2 1 1
MIRT440830 DEAF1 DEAF1, transcription factor 1 1
MIRT440866 CSNK1E casein kinase 1 epsilon 1 1
MIRT472232 NFIC nuclear factor I C 2 2
MIRT473190 MITF melanogenesis associated transcription factor 2 2
MIRT477856 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT497528 ZNF607 zinc finger protein 607 2 2
MIRT509770 SERTM1 serine rich and transmembrane domain containing 1 2 6
MIRT524407 CNTNAP5 contactin associated protein like 5 2 4
MIRT535209 PKIA cAMP-dependent protein kinase inhibitor alpha 2 4
MIRT554511 RUNX1T1 RUNX1 translocation partner 1 2 4
MIRT558069 ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 2 2
MIRT572273 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT574255 DOCK7 dedicator of cytokinesis 7 2 4
MIRT575621 Foxn3 forkhead box N3 2 2
MIRT575742 Zfp618 zinc finger protein 618 1 1
MIRT609050 VAMP4 vesicle associated membrane protein 4 2 2
MIRT611143 TNRC6B trinucleotide repeat containing 6B 2 4
MIRT699226 SLCO3A1 solute carrier organic anion transporter family member 3A1 2 2
MIRT703060 GTDC1 glycosyltransferase like domain containing 1 2 2
MIRT716005 ASB11 ankyrin repeat and SOCS box containing 11 2 2
MIRT731682 BTK Bruton tyrosine kinase 3 1
MIRT733090 DLEU2L deleted in lymphocytic leukemia 2-like 3 0
MIRT733091 BRCA2 BRCA2, DNA repair associated 3 0
MIRT733156 ITGA5 integrin subunit alpha 5 1 0
MIRT733501 GATA1 GATA binding protein 1 3 0
MIRT733503 SMAD2 SMAD family member 2 3 0
MIRT733525 MIR210HG MIR210 host gene 2 0
MIRT733615 TGFBI transforming growth factor beta induced 2 0
MIRT734175 KRAS KRAS proto-oncogene, GTPase 2 0
MIRT734293 PTEN phosphatase and tensin homolog 1 0
MIRT734568 STAT6 signal transducer and activator of transcription 6 1 0
MIRT734966 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 1 0
MIRT736294 ID2 inhibitor of DNA binding 2, HLH protein 1 0
MIRT737104 FABP4 fatty acid binding protein 4, adipocyte 3 0
MIRT756028 NTN4 netrin 4 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-210 Vincristine approved 5978 Quantitative real-time PCR Hep-2 cells 23780424 2013 up-regualted
miR-210 Lenalidomide approved 216326 Quantitative real-time PCR peripheral blood CD14+ monocytes 25287904 2014 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray lymphoblast cell line TK-6 17108120 2006 down-regulated
miR-210 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-210 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer MDA-MB231 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 down-regulated
miR-210 Trastuzumab approved NULL Microarray HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Quantitative real-time PCR HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 down-regulated
miR-210 Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-210 Bicalutamide approved 2375 Microarray prostate 22674191 2012 down-regulated
miR-210 Goserelin approved 47725 Microarray prostate 22674191 2012 down-regulated
miR-210 Olea europaea leaf extract NULL NULL Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Nicotine approved 89594 Microarray Rat adrenal pheochromocytoma PC12 cell 18845019 2009 down-regulated
miR-210 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-210 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-210 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-210 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-210 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-210 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-210 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-210-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 resistant
hsa-miR-210-3p (e)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-enal 5387396 NSC623175 resistant
hsa-miR-210-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 resistant
hsa-miR-210-3p [(E)-1-chloropropylideneamino] N-[2-(trifluoromethoxy)phenyl]carbamate 5466266 NSC682836 resistant
hsa-miR-210-3p [2-[(e)-(carbamothioylhydrazono)methyl]-6-methoxy-phenoxy]-hydroxy-copper; 2-(2-pyridyl)pyridine 135484845 NSC638302 resistant
hsa-miR-210-3p 1-(4-ethoxyphenyl)-3-(2-methyl-5-propan-2-ylphenyl)urea 240168 NSC46213 sensitive
hsa-miR-210-3p 1-(4-nitrophenyl)-3-(2-pyridyl)thiourea 3005383 NSC695329 sensitive
hsa-miR-210-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 resistant
hsa-miR-210-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 resistant
hsa-miR-210-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 resistant
hsa-miR-210-3p 17-acetyl-9,14-dihydroxy-16-methyl-15-(4-methylphenyl)-15-azatetracyclo[8.7.0.01,14.03,8]heptadeca-3,5,7,9,12,16-hexaene-2,11-dione 405612 NSC722982 resistant
hsa-miR-210-3p 1h-benz[g]indol-5-ol, 2-phenyl 371327 NSC645431 resistant
hsa-miR-210-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 resistant
hsa-miR-210-3p 2-[9-[(7-oxocyclohepta-1,3,5-trien-1-yl)amino]nonylamino]cyclohepta-2,4,6-trien-1-one 358331 NSC618296 resistant
hsa-miR-210-3p 2-amino-5,8-dihydroxy-1,4-naphthoquinone 377209 NSC658441 resistant
hsa-miR-210-3p 2-bromo-4-(5-fluoro-1,3-benzothiazol-2-yl)aniline 399248 NSC709925 sensitive
hsa-miR-210-3p 2-hydroxy-5-({(e)-[(10-hydroxyacridin-9(10h)-ylidene)methyl]diazenyl}sulfonyl)benzoic acid 363212 NSC627890 resistant
hsa-miR-210-3p 3'-chloro-3-nitro-o-salicylotoluidide 332278 NSC328477 resistant
hsa-miR-210-3p 3-((4-(methylthio)phenoxy)methyl)-2-oxiranol 366923 NSC636087 resistant
hsa-miR-210-3p 4-(2-phenylethylamino)naphthalene-1,2-dione 367789 NSC637731 resistant
hsa-miR-210-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 resistant
hsa-miR-210-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 resistant
hsa-miR-210-3p 4-[2-(methylamino)-1-methylsulfanylethyl]benzene-1,2-diol 412349 NSC39215 resistant
hsa-miR-210-3p 4-[4-(4-sulfinobutyldisulfanyl)butyldisulfanyl]butane-1-sulfinic acid 361262 NSC624205 resistant
hsa-miR-210-3p 4-acetamido-n-[(e)-(2,4-dichlorophenyl)methylideneamino]-2-methoxybenzamide 9572428 NSC716142 sensitive
hsa-miR-210-3p 4-aminodithiolane-4-carboxylic acid 269217 NSC109825 resistant
hsa-miR-210-3p 4-hydroxy-3-[1-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-3-phenylpropyl]naphthalene-1,2-dione 272651 NSC117274 resistant
hsa-miR-210-3p 4,4-dimethylspiro[1,3,2-oxazaphospholidin-2-ium-2,2'-3h-1,3,2-benzoxazaphosphol-2-ium]-5-one 6330525 NSC351866 resistant
hsa-miR-210-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 resistant
hsa-miR-210-3p 4h,7h-furo[2',3',4':4,5]naphth[2,1-e][1,3]oxazin-4-one, 8-(4-chlorophenyl)-8,9-dihydro- 373969 NSC651001 resistant
hsa-miR-210-3p 5,6,7-trimethoxy-N-(4H-pyrazolo[1,5-a]indol-2-yl)-1H-indole-2-carboxamide 404173 NSC720326 resistant
hsa-miR-210-3p 6-(3-chloropropyl)-3-nitroindeno[1,2-c]isoquinoline-5,11-dione 17755848 NSC731154 resistant
hsa-miR-210-3p 6-benzyloxyhexanal 389877 NSC686505 resistant
hsa-miR-210-3p 7-[(E)-2-(1,6-dimethylquinolin-1-ium-2-yl)ethenyl]-5-methylquinolin-8-ol 135483953 NSC86371 resistant
hsa-miR-210-3p 7-[(naphthalen-1-ylamino)(phenyl)methyl]quinolin-8-ol 256754 NSC84092 resistant
hsa-miR-210-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 resistant
hsa-miR-210-3p 7-o,8-o-isopropylidene iriomoteolide 3a 24808220 NSC753164 resistant
hsa-miR-210-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 resistant
hsa-miR-210-3p Acetyltrophanthidin 261075 NSC92954 resistant
hsa-miR-210-3p Adenosine, 2-bromo-2'-deoxy- 334838 NSC341936 resistant
hsa-miR-210-3p Asimicinone 393461 NSC695394 resistant
hsa-miR-210-3p Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 371025 NSC644902 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(2,4-dimethylphenyl)-3-methyl- 363228 NSC627974 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(4-chlorophenyl)-3,7,8-trimethyl- 363246 NSC627992 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 3-methyl-10-[3-(methylthio)phenyl]- 363242 NSC627988 resistant
hsa-miR-210-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 resistant
hsa-miR-210-3p Celcot rm 67277 NSC37168 resistant
hsa-miR-210-3p Cytarabine 6253 NSC287459 approved resistant
hsa-miR-210-3p Destruxin a 122810 NSC361126 resistant
hsa-miR-210-3p Di-p-tolyliodinium bromide 54601177 NSC8985 resistant
hsa-miR-210-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 resistant
hsa-miR-210-3p Dihydrorotenone 243725 NSC53866 resistant
hsa-miR-210-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 resistant
hsa-miR-210-3p Discorhabdin i 135409047 NSC656206 resistant
hsa-miR-210-3p Dpbq 364074 NSC629713 resistant
hsa-miR-210-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 resistant
hsa-miR-210-3p Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate 392845 NSC693857 resistant
hsa-miR-210-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 sensitive
hsa-miR-210-3p Gw612286x 9822610 NSC756278 sensitive
hsa-miR-210-3p Gw811761x 6539382 NSC756375 sensitive
hsa-miR-210-3p Herbimycin 6436247 NSC305978 resistant
hsa-miR-210-3p Hypothemycin 5458809 NSC354462 resistant
hsa-miR-210-3p Indole-2,3-dione, 5-methyl-, 3-[(o-nitrophenyl)hydrazone] 3632950 NSC117915 sensitive
hsa-miR-210-3p J3.572.907k 396709 NSC703318 resistant
hsa-miR-210-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 resistant
hsa-miR-210-3p Methyl 8-[(4-chlorophenyl)carbamoyl]naphthalene-1-carboxylate 364289 NSC630307 resistant
hsa-miR-210-3p N-(2-morpholin-4-ylethyl)-5-nitroquinolin-4-amine;hydrochloride 372042 NSC646859 resistant
hsa-miR-210-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 resistant
hsa-miR-210-3p N-(3,5-dicyano-2-(4-methylphenyl)-6-oxo-4-phenyl-1(6h)-pyridinyl)-4-methylbenzenesulfonamide 390286 NSC687578 resistant
hsa-miR-210-3p N-[(1E)-1-(1-hydroxypyridin-2-ylidene)ethyl]iminoazepane-1-carbothioamide 5369124 NSC351075 resistant
hsa-miR-210-3p N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide 389152 NSC684836 resistant
hsa-miR-210-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 resistant
hsa-miR-210-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 resistant
hsa-miR-210-3p Niosh/br9826000 359483 NSC620462 resistant
hsa-miR-210-3p NSC619321 NSC619321 sensitive
hsa-miR-210-3p NSC621321 NSC621321 resistant
hsa-miR-210-3p NSC631451 NSC631451 resistant
hsa-miR-210-3p NSC634766 NSC634766 resistant
hsa-miR-210-3p NSC635414 NSC635414 resistant
hsa-miR-210-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 resistant
hsa-miR-210-3p Pmp (van) 72508 NSC1906 resistant
hsa-miR-210-3p Scillirosidin, glycoside 222160 NSC7534 resistant
hsa-miR-210-3p Sesbanimide 163490 NSC355461 resistant
hsa-miR-210-3p Snc 80 123924 NSC707484 resistant
hsa-miR-210-3p Streptovaricin b 135443622 NSC156215 resistant
hsa-miR-210-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 resistant
hsa-miR-210-3p Tolonium chloride 7083 NSC36758 resistant
hsa-miR-210-3p Z48861686 4784054 NSC745813 resistant
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Trastuzumab resistant Low Breast Cancer tissue and cell line (BT-474, BTR65)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Vincristine 5978 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant Low Cervical Cancer tissue and cell line (SiHa, Cask)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-210-3p Fluorouracil + Oxaliplatin resistant High Colorectal Cancer tissue
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Prostate Cancer cell line (DU-145)
hsa-miR-210-3p Asparaginate 5460875 sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR20)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR70)
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive High Myeloma cell line (MM1R, MM1S)
hsa-miR-210-3p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive High Acute Myeloid Leukemia cell line (U-937, KG-1)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Ductal Adenocarcinoma cell line (MIA-PaCa-2)
hsa-miR-210-3p Trametinib 11707110 NSC758246 approved sensitive Low Melanoma cell line (MML-1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant Low Breast Cancer cell line (TAMR4, TAMR8)
hsa-miR-210-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p 1'-Acetoxychavicol acetate 119104 NSC711510 resistant Low Cervical Cancer cell line (Ca Ski, SiHa)
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Vinblastine 442111 NSC90636 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Cancer cell line (LS174T)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Cholangiocarcinoma cell line (KKU-213, KKU-055, KKU-100)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer tissue
hsa-miR-210-3p Palbociclib 5330286 NSC758247 approved sensitive High Breast Cancer cell line (T47D)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) sensitive High Metastatic Colorectal Cancer tissue
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (BXPC-3)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, HSC-3, HSC-4)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive Low Chronic Myelogenous Leukemia tissue
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant Low Renal Cell Cancer tissue
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant Low Glioma cell line (U87)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-210-3p Platinum 23939 resistant High High-Grade Serous Ovarian Cancer tissue
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (PLC/PRF5-R1, PLC/PRF5-R2, PLC/PRF5)
hsa-miR-210-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (A375)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (total RNA)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HeyA8)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM43)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-210-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-210-3p Exemestane 60198 NSC713563 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone 6013 NSC9700 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Exemestane resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Letrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Tamoxifen resistant cell line (MCF-7)
hsa-miR-210-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-210-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR4)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR200)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (100 nM)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (200 nM)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR1)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (H23)
hsa-miR-210-3p Cetuximab sensitive tissue (colorectal carcinoma)

Error report submission